Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
APOE mRNA is the messenger RNA product of the human APOE gene (chromosome 19), and it codes for Apolipoprotein E, a protein critical for lipid transport and cholesterol metabolism in both the periphery and the central nervous system. Differential expression and splicing of APOE mRNA lead to isoforms implicated in neurodegenerative and cardiovascular diseases, with the E4 allele conferring significantly increased risk for late-onset Alzheimer's disease, in part due to altered brain cholesterol homeostasis and increased amyloid plaque deposition[1][2][5]. Therapeutic strategies targeting APOE mRNA typically aim to reduce aberrant Apolipoprotein E levels, modify isoform expression, or influence downstream lipid metabolism[2][5]. Note: While protein targets (Apolipoprotein E) are more commonly referenced, APOE mRNA is an increasingly important molecular target in modern RNA-based drug development.
mRNA silencing or degradation (antisense oligonucleotides, siRNA) Transcriptional inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein E mRNA (APOE mRNA).